BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 35381189)

  • 1. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer's disease.
    Sadick JS; O'Dea MR; Hasel P; Dykstra T; Faustin A; Liddelow SA
    Neuron; 2022 Jun; 110(11):1788-1805.e10. PubMed ID: 35381189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-Scale Integration of Single-Cell RNA-Seq Data Reveals Astrocyte Diversity and Transcriptomic Modules across Six Central Nervous System Disorders.
    Qian Z; Qin J; Lai Y; Zhang C; Zhang X
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-cell transcriptome atlas of glial diversity in the human hippocampus across the postnatal lifespan.
    Su Y; Zhou Y; Bennett ML; Li S; Carceles-Cordon M; Lu L; Huh S; Jimenez-Cyrus D; Kennedy BC; Kessler SK; Viaene AN; Helbig I; Gu X; Kleinman JE; Hyde TM; Weinberger DR; Nauen DW; Song H; Ming GL
    Cell Stem Cell; 2022 Nov; 29(11):1594-1610.e8. PubMed ID: 36332572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered glia-neuron communication in Alzheimer's Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.
    Soelter TM; Howton TC; Clark AD; Oza VH; Lasseigne BN
    Cell Commun Signal; 2024 Jun; 22(1):317. PubMed ID: 38849813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy.
    Pai B; Tome-Garcia J; Cheng WS; Nudelman G; Beaumont KG; Ghatan S; Panov F; Caballero E; Sarpong K; Marcuse L; Yoo J; Jiang Y; Schaefer A; Akbarian S; Sebra R; Pinto D; Zaslavsky E; Tsankova NM
    Acta Neuropathol Commun; 2022 Oct; 10(1):149. PubMed ID: 36274170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology.
    Smith AM; Davey K; Tsartsalis S; Khozoie C; Fancy N; Tang SS; Liaptsi E; Weinert M; McGarry A; Muirhead RCJ; Gentleman S; Owen DR; Matthews PM
    Acta Neuropathol; 2022 Jan; 143(1):75-91. PubMed ID: 34767070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease.
    Kobayashi K; Hayashi M; Nakano H; Fukutani Y; Sasaki K; Shimazaki M; Koshino Y
    Neuropathol Appl Neurobiol; 2002 Jun; 28(3):238-51. PubMed ID: 12060348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glia-specific APOE epigenetic changes in the Alzheimer's disease brain.
    Tulloch J; Leong L; Thomson Z; Chen S; Lee EG; Keene CD; Millard SP; Yu CE
    Brain Res; 2018 Nov; 1698():179-186. PubMed ID: 30081037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.
    Fancy NN; Smith AM; Caramello A; Tsartsalis S; Davey K; Muirhead RCJ; McGarry A; Jenkyns MH; Schneegans E; Chau V; Thomas M; Boulger S; Cheung TKD; Adair E; Papageorgopoulou M; Willumsen N; Khozoie C; Gomez-Nicola D; Jackson JS; Matthews PM
    Acta Neuropathol; 2024 May; 147(1):78. PubMed ID: 38695952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease.
    Galea E; Weinstock LD; Larramona-Arcas R; Pybus AF; Giménez-Llort L; Escartin C; Wood LB
    Neurobiol Dis; 2022 May; 166():105655. PubMed ID: 35143967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease.
    Lee SH; Rezzonico MG; Friedman BA; Huntley MH; Meilandt WJ; Pandey S; Chen YJ; Easton A; Modrusan Z; Hansen DV; Sheng M; Bohlen CJ
    Cell Rep; 2021 Dec; 37(13):110158. PubMed ID: 34965428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Glia-Neuron Communication in Alzheimer's Disease Affects WNT, p53, and NFkB Signaling Determined by snRNA-seq.
    Soelter TM; Howton TC; Clark AD; Oza VH; Lasseigne BN
    bioRxiv; 2024 May; ():. PubMed ID: 38076822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications.
    Arranz AM; De Strooper B
    Lancet Neurol; 2019 Apr; 18(4):406-414. PubMed ID: 30795987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity and Molecular Markers for CNS Glial Cells Revealed by Single-Cell Transcriptomics.
    Sun J; Song Y; Chen Z; Qiu J; Zhu S; Wu L; Xing L
    Cell Mol Neurobiol; 2022 Nov; 42(8):2629-2642. PubMed ID: 34704168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression.
    Saito ER; Miller JB; Harari O; Cruchaga C; Mihindukulasuriya KA; Kauwe JSK; Bikman BT
    Alzheimers Dement; 2021 Sep; 17(9):1474-1486. PubMed ID: 33650792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-Associated Neurotoxic Astrocyte Markers in Alzheimer Disease Based on Integrative Single-Nucleus RNA Sequencing.
    Yu W; Li Y; Zhong F; Deng Z; Wu J; Yu W; Lü Y
    Cell Mol Neurobiol; 2024 Feb; 44(1):20. PubMed ID: 38345650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer's Disease Datasets Reveals
    Belonwu SA; Li Y; Bunis DG; Rao AA; Solsberg CW; Oskotsky T; Taubes AL; Grone B; Zalocusky KA; Fragiadakis GK; Huang Y; Sirota M
    Front Aging Neurosci; 2022; 14():749991. PubMed ID: 35572130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.
    Li Z; Del-Aguila JL; Dube U; Budde J; Martinez R; Black K; Xiao Q; Cairns NJ; ; Dougherty JD; Lee JM; Morris JC; Bateman RJ; Karch CM; Cruchaga C; Harari O
    Genome Med; 2018 Jun; 10(1):43. PubMed ID: 29880032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte subtype-specific approach to Alzheimer's disease treatment.
    Sarkar S; Biswas SC
    Neurochem Int; 2021 May; 145():104956. PubMed ID: 33503465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
    Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
    Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.